Search

everythinglearnresearchcommunity

for

Search:↓

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Blocking IL-17 signaling may reduce skin inflammation and delay aging.

IL-17 inhibitors for psoriasis may cause unexpected hair loss.

The protein p53 directly reduces the production of Keratin 17, a skin and hair protein, in rats with radiation dermatitis.

Terbinafine effectively treated kerion celsi despite disrupted immune responses.

Clascoterone safely promotes hair growth similar to minoxidil.

S100A7 and IL-17 may contribute to inflammation in lichen planopilaris.

Blocking IL-17a can improve age-related smell loss in mice.

Higher IL-17A and IL-23 levels are linked to alopecia areata severity and could help in tracking and treating the disease.

Higher levels of IL-17A and IL-2 are linked to alopecia areata.

Targeting IL-17 could help treat pattern hair loss.

Higher IL-17A levels indicate more severe alopecia areata.

A reliable method was created to measure dutasteride and related molecules in capsules.

Cortexolone 17a-propionate may be an effective new treatment for hair loss.

Clofazimine may be effective for treating ashy dermatosis.

Keratin 17 is modified by RSK1 in response to growth and stress, affecting skin growth and stress response.

Psoriasis patients' immune response to a hair protein depends on their specific gene type.

Combination of 17α-estradiol and minoxidil improves hair growth and reduces hair loss in most patients.

Keratins 6, 16, and 17 increase in damaged or diseased skin and may help diagnose skin issues.

A woman with frontal fibrosing alopecia experienced unusual hair growth after using a specific topical lotion.

Minoxidil can cause a skin reaction called ALEP.

Netherton syndrome has two subtypes with shared immune traits but different allergic and immune responses, suggesting targeted treatments.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

New pregnane derivatives are effective at inhibiting an enzyme linked to hair loss and reducing oil gland activity.

New acne treatments show promise as alternatives to traditional therapies.

Mesenchymal stem cells in people with Hidradenitis Suppurativa are more inflammatory, possibly contributing to the disease.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

Secukinumab effectively treated a difficult case of folliculitis decalvans.

Hair follicles play a crucial role in regulating skin barrier function.